Alprostadil 500 mcg in 1 mL Injection
RxNorm 237212
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 237212 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: alprostadil 500 mcg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
1 mL alprostadil 0.5 mg/ML Injection
(Atom ID: 12333477)
PSNPrescribable
Prescribable Name (PSN):
Alprostadil 500 mcg in 1 mL Injection
(Atom ID: 7273154)
SYPrescribable
Synonym (SY):
Alprostadil 500 mcg per 1 mL Injection
(Atom ID: 7273155)
PTPrescribable
Designated preferred name (PT):
Alprostadil 500 microgram/mL solution for infusion and/or injection
(Atom ID: 12754634)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely alprostadil 500 microgram/1 mL conventional release solution for infusion and/or injection (clinical drug)
(Atom ID: 12756929)
Patient Education
Alprostadil Urogenital
Alprostadil injection and suppositories are used to treat certain types of erectile dysfunction (impotence; inability to get or keep an erection) in men. Alprostadil injection is also sometimes used in combination with other tests to diagnose erectile dysfunction. Alprostadil is in a class of medications called vasodilators. It works by relaxing the muscles and blood vessels in the penis to keep enough blood in the penis so that an erection can occur. Alprostadil does not cure erectile dysfunction or increase sexual desire. Alprostadil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).
[Learn More]
* Please review the disclaimer below.